Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1Phase 1/2 1

Status

Completed 28Terminated 11Unknown 4Active not recruiting 3Not yet recruiting 2Withdrawn 1Recruiting 1

Sponsor Class

OTHER 2NIH 2

Study Type

Interventional 4

Sponsor

Cancer Type

Other hematologic neoplasm 4Myeloid 4

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 17Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Gastrointestinal Stromal Tumors 6Leukemia, Myeloid, Chronic-Phase 4Leukemia 4Neoplasms 2Neoplasm Metastasis 2Melanoma 2Sarcoma 1Relapsed Pediatric Solid Tumor 1Mesothelioma 1Meningioma 1Leukemia, Myeloid 1Head and Neck Neoplasms 1Gastrointestinal Neoplasms 1GIST 1Drug-Related Side Effects and Adverse Reactions 1Chordoma 1Central Nervous System Neoplasms 1Carcinoma, Adenoid Cystic 1Brain Neoplasms 1

Interventions

Cyclophosphamide 6fludarabine phosphate 5Busulfan 5Peripheral Blood Stem Cell Transplantation 4Mycophenolic Acid 4Imatinib Mesylate 4Hydroxyurea 4Cytarabine 4Antilymphocyte Serum 4Radiotherapy 3Melphalan 3Interferon-alpha 3Dasatinib 3olverembatinib 2Tacrolimus 2Polymerase Chain Reaction 2Methylprednisolone 2Idarubicin 2Filgrastim 2Cyclosporine 2Cord Blood Stem Cell Transplantation 2sargramostim 1nilotinib 1inecalcitol 1flumatinib 1danusertib 1avelumab 1Whole-Body Irradiation 1Tyrosine Kinase Inhibitors 1Rituximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × Leukemia, Myeloid, Chronic-Phase × Imatinib Mesylate × Clear all
NCT03515018 2018-05-22

HU

First Affiliated Hospital of Harbin Medical University

Phase 3 Unknown
60 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

NCT00028847 2013-09-17

Imatinib Mesylate and Cytarabine in Treating Patients With Newly Diagnosed Chronic Myeloid Leukemia

National Cancer Institute (NCI)

Phase 1/2 Unknown
60 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

NCT01227135 2011-11-30

Imatinib Mesylate With or Without Hydroxychloroquine in Treating Patients With Chronic Myeloid Leukemia

University of Glasgow

Phase 2 Unknown
66 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

NCT00112775 2011-06-07

BMS-354825 or Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Did Not Respond to Previous Imatinib Mesylate

National Cancer Institute (NCI)

Phase 2 Unknown
MyeloidOther hematologic neoplasm

Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

Data powered by HemOnc (CC BY 4.0) Colophon âš¡